Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Eton Pharmaceuticals, Inc. ETON

Full chart Compare
Set alert

Price alert · ETON

All alert types
56.46 USD +9.31 (+19.75%)

At closeNov 6, 2026, 6:32 PM EST

56.80 +0.34 +0.60%

After hours · Nov 6, 6:32 PM ET

51.82 Day range 58.59
14.35 52-week range 64.43
YTD
+233.89%
1 year
+194.98%

Financial health

Altman Z-Score

14.91 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B3 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 2
  • P/E 2
  • P/B 1

Valuation

P/E -99.5×
FY 2017: -15.2×FY 2018: -3.1×FY 2019: -7.1×FY 2020: -6.1×FY 2021: -55.3×FY 2022: -7.8×FY 2023: -120×FY 2024: -88.8×FY 2025: -99.5×
FY 2017 5y median -88.8× FY 2025
P/S 5.7×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 133×FY 2020: 4380×FY 2021: 5.0×FY 2022: 3.3×FY 2023: 3.5×FY 2024: 8.8×FY 2025: 5.7×
FY 2017 5y median 5.0× FY 2025
P/B 17.4×
FY 2017: 9.0×FY 2018: 1.5×FY 2019: 12.1×FY 2020: 10.9×FY 2021: 6.1×FY 2022: 5.4×FY 2023: 7.3×FY 2024: 14.1×FY 2025: 17.4×
FY 2017 5y median 7.3× FY 2025
P/FCF 44.6×
FY 2017: -22.5×FY 2018: -4.7×FY 2019: -6.4×FY 2020: -7.6×FY 2021: -13.6×FY 2022: 34.9×FY 2023: 18.6×FY 2024: 366×FY 2025: 44.6×
FY 2017 5y median 34.9× FY 2025
EV/EBITDA 108×
FY 2017: -13.4×FY 2018: -1.2×FY 2019: -6.6×FY 2020: -5.9×FY 2021: -67.3×FY 2022: -8.4×FY 2023: 454×FY 2024: -548×FY 2025: 108×
FY 2017 5y median -8.4× FY 2025
EV/Sales 5.8×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 126×FY 2020: 4017×FY 2021: 4.6×FY 2022: 2.9×FY 2023: 3.0×FY 2024: 9.2×FY 2025: 5.8×
FY 2017 5y median 4.6× FY 2025
FCF Yield 2.2%
FY 2017: -4.4%FY 2018: -21.3%FY 2019: -15.5%FY 2020: -13.1%FY 2021: -7.4%FY 2022: 2.9%FY 2023: 5.4%FY 2024: 0.3%FY 2025: 2.2%
FY 2017 5y median 2.2% FY 2025

Profitability

Gross Margin 53.5%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 52.8%FY 2020: -633.3%FY 2021: 88.0%FY 2022: 67.4%FY 2023: 66.6%FY 2024: 60.0%FY 2025: 53.5%
FY 2017 5y median 66.6% FY 2025
Operating Margin 0.1%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -1939.6%FY 2020: -69515.4%FY 2021: -6.8%FY 2022: -38.9%FY 2023: -3.8%FY 2024: -6.7%FY 2025: 0.1%
FY 2017 5y median -6.7% FY 2025
Net Margin -5.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -1910.3%FY 2020: -71717.9%FY 2021: -9.0%FY 2022: -42.4%FY 2023: -3.0%FY 2024: -9.8%FY 2025: -5.8%
FY 2017 5y median -9.0% FY 2025
ROE -17.6%
FY 2017: -59.0%FY 2018: -48.4%FY 2019: -173.6%FY 2020: -178.6%FY 2021: -11.1%FY 2022: -69.0%FY 2023: -6.0%FY 2024: -15.7%FY 2025: -17.6%
FY 2017 5y median -15.7% FY 2025
ROIC 0.1%
FY 2017: -56.5%FY 2018: -39.2%FY 2019: -123.1%FY 2020: -118.9%FY 2021: -6.1%FY 2022: -42.1%FY 2023: -5.7%FY 2024: -4.6%FY 2025: 0.1%
FY 2017 5y median -5.7% FY 2025
ROA -5.0%
FY 2017: -53.2%FY 2018: -45.0%FY 2019: -107.3%FY 2020: -106.3%FY 2021: -7.1%FY 2022: -36.0%FY 2023: -2.9%FY 2024: -5.0%FY 2025: -5.0%
FY 2017 5y median -5.0% FY 2025

Growth (YoY)

Revenue 104.9%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -95.9%FY 2021: 55879.5%FY 2022: -2.7%FY 2023: 48.9%FY 2024: 23.3%FY 2025: 104.9%
FY 2017 FY 2025
Operating Income 102.8%
FY 2017: 0.0%FY 2018: -44.3%FY 2019: -80.2%FY 2020: -45.8%FY 2021: 94.5%FY 2022: -452.5%FY 2023: 85.6%FY 2024: -117.9%FY 2025: 102.8%
FY 2017 FY 2025
EPS (diluted) -13.3%
FY 2017: 0.0%FY 2018: -385.4%FY 2019: 48.7%FY 2020: -30.4%FY 2021: 94.2%FY 2022: -363.9%FY 2023: 89.9%FY 2024: -311.0%FY 2025: -13.3%
FY 2017 FY 2025
Free Cash Flow 980.7%
FY 2017: 0.0%FY 2018: -72.9%FY 2019: -137.1%FY 2020: -12.7%FY 2021: 64.4%FY 2022: 125.5%FY 2023: 197.1%FY 2024: -84.4%FY 2025: 980.7%
FY 2017 FY 2025

Financial Health

Current Ratio 1.6×
FY 2017: 16.8×FY 2018: 13.6×FY 2019: 7.6×FY 2020: 6.5×FY 2021: 5.2×FY 2022: 3.1×FY 2023: 1.7×FY 2024: 2.1×FY 2025: 1.6×
FY 2017 5y median 2.1× FY 2025
Quick Ratio 1.2×
FY 2017: 16.8×FY 2018: 13.6×FY 2019: 7.5×FY 2020: 6.2×FY 2021: 5.1×FY 2022: 3.0×FY 2023: 1.6×FY 2024: 1.3×FY 2025: 1.2×
FY 2017 5y median 1.6× FY 2025
Debt / Equity 1.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.4×FY 2020: 0.5×FY 2021: 0.4×FY 2022: 0.5×FY 2023: 0.3×FY 2024: 1.2×FY 2025: 1.2×
FY 2017 5y median 0.5× FY 2025
Net Debt / EBITDA 1.2×
FY 2017: 1.8×FY 2018: 2.6×FY 2019: 0.4×FY 2020: 0.5×FY 2021: 5.2×FY 2022: 1.3×FY 2023: -75.4×FY 2024: -22.9×FY 2025: 1.2×
FY 2017 5y median 1.2× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -30.5×FY 2021: -1.4×FY 2022: -8.6×FY 2023: -1.1×FY 2024: -1.3×FY 2025: 0.0×
FY 2017 5y median -1.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 2.7%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: -8.2%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31